In the restless silence of those seeking focus amidst the whirlwind of the mind, a question echoes: could cannabis offer relief for individuals with Attention Deficit Hyperactivity Disorder (ADHD)?

Thinking of comforting those seeking quality of life, the Rio de Janeiro State Court of Justice (TJRJ) has just made available on its Portal of Law and Health a systematic review on the use of cannabis-based medications in the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

The study, entitled “Cannabis Derivatives and Their Synthetic Analogues for Attention Deficit Hyperactivity Disorder,” was prepared by the Health Technology Assessment Center and the Evidence Center of Hospital Sírio-Libanês (NATS/NEv-HSL) and published on September 5th.

The review aimed to verify if medical cannabis could bring benefits to individuals with ADHD, evaluating impacts on symptoms, quality of life, and potential risks. The researchers gathered available information, synthesized the findings, and analyzed the robustness of the data. They checked if the evidence was solid enough to draw conclusions about the benefits and risks of cannabis use.

The full material can be accessed on the Portal of Law and Health, which gathers technical content aimed at supporting judges and servers in decisions related to public and supplementary health judicial demands.

Read More

Can cannabis treat ADHD after all?

Benefits of medicinal cannabis use in the treatment of Attention Deficit Hyperactivity Disorder (ADHD)